New findings shed light on the formation of microtubule structures that support cellular processes ranging from cell division to intracellular transport.

Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

It’s not often that a keynote speaker will ask his audience to close their eyes and tune him out, but that’s what Aviad “Adi” Haramati, PhD, did when delivering the 2018 John E. Chapman Lecture.

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.

An improved technology enables high-throughput protein identification in imaging mass spectrometry, aiding proteomics research.

New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.